These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 108833)

  • 1. [Comparative evaluation of treatment results of melanoblastoma of the limbs with or without perfusion chemotherapy].
    Levin AO; Stepanova NS; Chikinda IuN
    Vestn Khir Im I I Grek; 1979 Feb; 122(2):53-6. PubMed ID: 108833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Various aspects of treatment of primary melanoblastoma of the extremities by regional perfusion].
    Schraffordt Koops H; Eibergen R; Oldhoff J; van der Ploegen E; Vermey A
    Ned Tijdschr Geneeskd; 1975 Nov; 119(45):1746-53. PubMed ID: 1214883
    [No Abstract]   [Full Text] [Related]  

  • 3. [Extensive lymphadenectomy and perfusion chemotherapy in the treatment of pigmented skin tumors of the lower extremities].
    Kolesov VI; Levin AO; Martyniuk VV; Sidorenko LN; Stepanova NS
    Vestn Khir Im I I Grek; 1970 Jun; 104(6):68-73. PubMed ID: 4992349
    [No Abstract]   [Full Text] [Related]  

  • 4. [Combined treatment of malignant tumors of the extremities. Regional perfusion chemotherapy].
    Kolessov VI; Levin AO
    Minerva Med; 1970 Sep; 61(71):3673-5. PubMed ID: 4989391
    [No Abstract]   [Full Text] [Related]  

  • 5. [Randomized melanoma study of perfusion of the extremities. Results of treatment 2 1/2 years after premature discontinuation].
    Ghussen F; Krüger I; Groth W; Stützer H
    Chirurg; 1986 Oct; 57(10):619-23. PubMed ID: 3539548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy of melanoma of the extremities by perfusion: fourteen years clinical experience.
    Krementz ET; Ryan RF
    Ann Surg; 1972 Jun; 175(6):900-17. PubMed ID: 4625027
    [No Abstract]   [Full Text] [Related]  

  • 7. Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs.
    Klop WM; Vrouenraets BC; van Geel BN; Eggermont AM; Klaase JM; Nieweg OE; Kroon BB
    J Am Coll Surg; 1996 Jun; 182(6):467-72. PubMed ID: 8646345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy by regional perfusion for limb melanoma.
    Krementz ET; Carter RD; Sutherland CM; Muchmore JH
    Am Surg; 1987 Mar; 53(3):133-40. PubMed ID: 3103506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperthermic isolated limb perfusion (HILP) in malignant melanoma. Experience with 101 patients.
    Knorr C; Meyer T; Janssen T; Goehl J; Hohenberger W
    Eur J Surg Oncol; 2006 Mar; 32(2):224-7. PubMed ID: 16289716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normothermic isolation perfusion with melphalan for advanced melanoma of the limbs.
    Kroon BB; Van Geel AN; Benckhuijsen C; Wieberdink J
    Anticancer Res; 1987; 7(3 Pt B):441-2. PubMed ID: 3631900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there an indication for a double perfusion schedule with melphalan for patients with recurrent melanoma of the limbs?
    Klaase JM; Kroon BB; van Geel AN; Eggermont AM; Franklin HR; van Dongen JA
    Melanoma Res; 1994 Mar; 4 Suppl 1():13-6. PubMed ID: 8038589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perfusion of melanoma. 133 isolated perfusions in 114 patients.
    Golomb FM
    Panminerva Med; 1976; 18(1-2):8-10. PubMed ID: 813172
    [No Abstract]   [Full Text] [Related]  

  • 13. [Adjuvant regional isolation perfusion of the extremities of patients with stage I melanoma thicker than 1.5 mm].
    Kroon BB; Schraffordt Koops H
    Ned Tijdschr Geneeskd; 1990 Oct; 134(42):2042-7. PubMed ID: 2234177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical chemotherapy in the management of melanoblastoma of the lower extremities.
    Rahóty P; Besznyák I; Erdélyi-Tóth V; Sulvok Z; Péley G
    Acta Chir Hung; 1997; 36(1-4):282-3. PubMed ID: 9408375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of hyperthermic perfusion for melanoma of the extremities.
    Stehlin JS; Giovanella BC; de Ipolyi PD; Muenz LR; Anderson RF
    Surg Gynecol Obstet; 1975 Mar; 140(3):339-48. PubMed ID: 1114425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surgical treatment and regional chemotherapy in melanoma of the extremities].
    Henneking K; Binder J; Weyers W; Schwemmle K
    Chirurg; 1993 Feb; 64(2):134-8. PubMed ID: 8462350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Surgical treatment of malignant melanoma of the limbs combined with thermochemotherapy under extracorporeal circulation].
    Truchetet F; Grosshans E; Kretz JG; Bartier JC; Laplanche G
    Ann Dermatol Venereol; 1988; 115(5):573-85. PubMed ID: 3195954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of in-transit metastases from cutaneous melanoma by isolation perfusion with tumour necrosis factor-alpha (TNF-alpha), melphalan and interferon-gamma (IFN-gamma). Dose-finding experience at the National Cancer Institute of Milan.
    Vaglini M; Santinami M; Manzi R; Inglese MG; Santoro N; Persiani L; Belli F
    Melanoma Res; 1994 Mar; 4 Suppl 1():35-8. PubMed ID: 8038594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival after regional perfusion for limb melanoma.
    Cox KR
    Aust N Z J Surg; 1975 Feb; 45(1):32-6. PubMed ID: 808204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palliation of regional symptoms of advanced extremity melanoma by isolated limb perfusion with melphalan and high-dose tumor necrosis factor.
    Fraker DL; Alexander HR; Andrich M; Rosenberg SA
    Cancer J Sci Am; 1995; 1(2):122-30. PubMed ID: 9166465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.